Ascletis Pharma Inc.
ASCLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $865,730 | $330,117 | $2,470,834 | $2,495,496 |
| Short-Term Investments | $1,081,801 | $1,969,286 | $2,078,266 | $5,200 |
| Receivables | $5,142 | $5,432 | $23,873 | $53,606 |
| Inventory | $4,373 | $6,071 | $20,519 | $56,233 |
| Other Curr. Assets | $13,736 | $18,007 | $18,300 | $21,016 |
| Total Curr. Assets | $1,970,782 | $2,332,756 | $2,544,726 | $2,631,551 |
| Property Plant & Equip (Net) | $57,204 | $68,277 | $73,041 | $77,921 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $12,118 | $26,315 | $16,559 | $78,213 |
| Long-Term Investments | -$997,410 | $63,024 | $10,818 | $36,658 |
| Tax Assets | $0 | $0 | -$10,818 | $0 |
| Other NC Assets | $1,081,878 | $637 | $22,716 | $5,616 |
| Total NC Assets | $153,790 | $158,253 | $112,316 | $198,408 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,124,572 | $2,491,009 | $2,657,042 | $2,829,959 |
| Liabilities | – | – | – | – |
| Payables | $31 | $649 | $3,135 | $1,054 |
| Short-Term Debt | $6,246 | $5,710 | $2,416 | $1,568 |
| Tax Payable | $4,078 | $1,722 | $1,553 | $3,959 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $142,698 | $132,598 | $101,085 | $84,390 |
| Total Curr. Liab. | $153,053 | $140,679 | $108,189 | $90,971 |
| LT Debt | $1,387 | $2,706 | $1,821 | $1,182 |
| Deferred Rev, NC | $3,970 | $5,558 | $7,146 | $8,734 |
| Deferred Tax Liab, NC | $0 | -$5,558 | -$7,146 | -$8,734 |
| Other NC Liab. | $0 | $5,558 | $7,146 | $8,734 |
| Total NC Liab. | $5,357 | $8,264 | $8,967 | $9,916 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7,633 | $8,416 | $4,237 | $2,750 |
| Total Liabilities | $158,410 | $148,943 | $117,156 | $100,887 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $689 | $731 | $742 | $746 |
| Retained Earnings | -$1,475,339 | -$1,174,403 | -$1,029,688 | -$714,845 |
| AOCI | $747,551 | $724,556 | $702,001 | $578,322 |
| Other Equity | $2,693,261 | $2,791,182 | $2,866,831 | $2,864,849 |
| Total Equity | $1,966,162 | $2,342,066 | $2,539,886 | $2,729,072 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,124,572 | $2,491,009 | $2,657,042 | $2,829,959 |
| Net Debt | -$858,097 | -$321,701 | -$2,466,597 | -$2,492,746 |